Effects of Dance and Music Appreciation on Brain Health and Fitness in People at Risk for Alzheimer's Disease
IGROOVE
Establishing the Optimal Frequency of Dance Movement for Neurocognitive and Physical Outcomes in People at Risk of Alzheimer's Disease
2 other identifiers
interventional
165
1 country
1
Brief Summary
The purpose of this research study is to study the effects of dance movement and music on memory and cardiorespiratory fitness in older adults who are concerned about memory loss. The study aims to determine the optimal number of movement or music appreciation classes a week to support brain health and fitness. Participants will be people 62 years or older who are concerned about their memory, but do not yet have a diagnosis of cognitive impairment. If a participant is deemed qualified to participate, he/she will be placed into one of four groups and will attend 1, 2, or 3 group or music appreciation classes per week for 24 weeks (6 months). In addition to attending the group classes, participants will be asked to complete at least four study visits at Wake Forest Baptist Medical Center to complete various clinical assessments, including a brain MRI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable alzheimer-disease
Started Apr 2023
Longer than P75 for not_applicable alzheimer-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 17, 2022
CompletedFirst Posted
Study publicly available on registry
August 19, 2022
CompletedStudy Start
First participant enrolled
April 24, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2027
March 17, 2026
March 1, 2026
3.9 years
August 17, 2022
March 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Peak Oxygen Consumption (VO2)
Assessed with Graded Exercise Test (GXT) Peak oxygen consumption, a marker of cardiorespiratory fitness (ml/kg/min) Shows effect on Cardio Respiratory Function.
Baseline
Peak Oxygen Consumption (VO2)
Assessed with Graded Exercise Test (GXT) Peak oxygen consumption, a marker of cardiorespiratory fitness (ml/kg/min) Shows effect on Cardio Respiratory Function.
Month 1
Peak Oxygen Consumption (VO2)
Assessed with Graded Exercise Test (GXT) Peak oxygen consumption, a marker of cardiorespiratory fitness (ml/kg/min) Shows effect on Cardio Respiratory Function.
Month 3
Peak Oxygen Consumption (VO2)
Assessed with Graded Exercise Test (GXT) Peak oxygen consumption, a marker of cardiorespiratory fitness (ml/kg/min) Shows effect on Cardio Respiratory Function.
Month 6
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Shows effect on Cognitive Function. Overall score from the RBANS; Average/Mild Impairment (standard scores of 70 or above), Moderate Impairment (standard scores from 55 to 69), and Severe Impairment (standard scores \<54) Scores range from 40 to 160.
Baseline
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Shows effect on Cognitive Function. Overall score from the RBANS; Average/Mild Impairment (standard scores of 70 or above), Moderate Impairment (standard scores from 55 to 69), and Severe Impairment (standard scores \<54) Scores range from 40 to 160.
Month 1
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Shows effect on Cognitive Function. Overall score from the RBANS; Average/Mild Impairment (standard scores of 70 or above), Moderate Impairment (standard scores from 55 to 69), and Severe Impairment (standard scores \<54) Scores range from 40 to 160.
Month 3
Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)
Shows effect on Cognitive Function. Overall score from the RBANS; Average/Mild Impairment (standard scores of 70 or above), Moderate Impairment (standard scores from 55 to 69), and Severe Impairment (standard scores \<54) Scores range from 40 to 160.
Month 6
Secondary Outcomes (2)
Class Attendance
Week 24
Exercise Self-Efficacy
Baseline, Month 1, Month 3, Month 6
Other Outcomes (10)
Expanded short physical performance battery (eSPPB)
Baseline, Month 1, Month 3, Month 6
Gait Variability
Baseline, Month 1, Month 3, Month 6
Postural Sway
Baseline, Month 1, Month 3, Month 6
- +7 more other outcomes
Study Arms (4)
Dance 3 Times Weekly (3xD)
EXPERIMENTALParticipants in this arm will attend classes 3 times a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Dance 2 Times Weekly (2xD)
EXPERIMENTALParticipants in this arm will attend classes 2 times a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Dance 1 Time Weekly (1xD)
EXPERIMENTALParticipants in this arm will attend a class 1 time a week for 24 weeks. During the 24 weeks, four different dance forms will be practiced. Each dance form will be taught for 6 weeks.
Music Appreciation Classes (MAC)
ACTIVE COMPARATORIn the MAC, the music associated with that dance form will be used as the subject for classes and will also change every 6 weeks.
Interventions
Four Different dance forms taught for 6 weeks each
Eligibility Criteria
You may qualify if:
- Cognitive Change Index score ≥16
- Montreal Cognitive Assessment (MoCA) score ≥21
- Cognitively normal
- Low-active for past 6 months (\<30 min, 3 days/week of exercise, including walking for exercise)
- MRI compatible
- Willing and able to complete exercise testing.
- Has reliable transportation or is able to use transportation provided by the study.
- English speaking (needed for group class participation)
You may not qualify if:
- Unable or unwilling to attend intervention classes 1-3x/week
- Current diagnosis of a major neurological disorder (Alzheimer's disease, Lewy body dementia, Frontotemporal dementia, Parkinson's disease, amyotrophic lateral sclerosis, etc.)
- Unwilling or unable to provide consent for study participation.
- Taking medication during the intervention times that could negatively influence safety
- Current cancer treatment or other major medical problems that might independently affect cognition or movement or interfere with ability to attend intervention or study visits.
- Chronic vertigo.
- Enrolled in another interventional research study ≤3 months prior to beginning this study.
- Hip fracture, hip or knee replacement, or spinal surgery in past 6 months.
- Health contraindications for completing a graded exercise test and movement intervention, including uncontrolled hypertension (BP\>200/110 mmHg), hypertriglyceridemia (TG\>400 mg/dl), uncontrolled diabetes (HbA1c \> 7.5), clinical evidence of anemia.
- Self-reports regularly drinking \> 14 alcoholic beverages a week or current illicit drug use.
- Unable or unwilling to understand study procedures and comply with them for the duration of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest School of Medicine
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christina Hugenschmidt, PhD
Wake Forest University Health Sciences
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2022
First Posted
August 19, 2022
Study Start
April 24, 2023
Primary Completion (Estimated)
March 31, 2027
Study Completion (Estimated)
March 31, 2027
Last Updated
March 17, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share